title: Involvement of interleukin-1beta in zinc deficiency-induced intestinal damage and beneficial effect of cyclosporine A.
abstract: In a previous study we have shown that zinc deficiency caused several alterations in intestine of rats. Here we report that interleukin-1beta (IL-1beta) is involved in the zinc deficiency-induced mucosal damage and that cyclosporine A (CsA) protects the intestine against both structural and functional alterations by different mechanisms. The zinc deficient (ZD) rats were maintained on a zinc deficient diet for 40 days. They received a daily injection of CsA (12 mg/kg) for the last 10 days. The histological analysis of small intestine revealed that the dramatic alterations induced by zinc deficiency (ulcerations, inflammation, edema, vasodilatation), were not present after CsA treatment. The IL-1beta gene expression, analyzed by PCR, was increased in the three intestinal regions of ZD rats, as compared to C rats. There was a relation between increasing IL-1beta expression and increased severity of damage, and the highest cytokine elevation was in the most damaged region, i.e. the jejunum. After CsA administration the IL-1beta mRNA was similar to control rats. The intestinal cell proliferation, measured as crypt cell production rate and labelling index, as well the cell renewal, measured as cell migration rate and turnover time, were affected by zinc deficiency. After CsA treatment, all these variables were similar to control rats, suggesting that CsA induces a stimulation of intestinal cell proliferation in zinc deficiency. Finally, the decrease in the disaccharidase activities induced by zinc deficiency was abrogated by CsA treatment.
authors.affiliation: Istituto Nazionale della Nutrizione, Roma, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Vignolini
authors.forename: F
authors.initials: F
authors.lastname: Nobili
authors.forename: E
authors.initials: E
authors.lastname: Mengheri
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000494:pharmacology*; D003677:Deficiency Diseases / Q000201:enzymology / Q000473:pathology / Q000503:physiopathology; D015870:Gene Expression; D007375:Interleukin-1 / Q000235:genetics / Q000502:physiology*; D007422:Intestines / Q000187:drug effects / Q000201:enzymology / Q000473:pathology*; D008297:Male; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D013393:Sucrase / Q000378:metabolism; D015032:Zinc / Q000172:deficiency*; D000520:alpha-Glucosidases / Q000378:metabolism
chemical_list: D007375:Interleukin-1; D012333:RNA, Messenger; D016572:Cyclosporine; D000520:alpha-Glucosidases; D013393:Sucrase; D015032:Zinc